GENNADY RUBINSTEIN M.D. NPI 1720083744

NPI Details

Gennady Rubinstein, M.D. is a dermatology in Studio City, CA with 27 years of experience. The provider is a dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging. Gennady Rubinstein, M.D. NPI is 1720083744. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: BOSTON UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1999

The provider's business location address is:

3959 LAUREL CANYON BLVD
SUITE F
STUDIO CITY, CA
ZIP 91604-921
Phone: (818) 505-9300
Fax: (818) 505-9292

The NPI 1720083744 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The CLIA number assigned to this NPI record is 05D2117561 - physician office with a certificate type of Certificate of Compliance.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Destruction of precancer skin growth, 2-14 growths (HCPCS:17003)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Destruction of skin growth, 1-14 growths (HCPCS:17110)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Biopsy of related skin growth, first growth (HCPCS:11102)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Destruction of skin growth, 15 or more growths (HCPCS:17111)
• Epifix, per square centimeter (HCPCS:Q4186)
• Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) (HCPCS:J7308)
• Application of light with debridement to destroy precancer skin growth (HCPCS:96574)
• Injection into skin growth, 1-7 growths (HCPCS:11900)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Destruction of precancer skin growth, 15 or more growths (HCPCS:17004)
• Biopsy of related skin growth, each additional growth (HCPCS:11103)
• Simple or single drainage of skin abscess (HCPCS:10060)
• Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks (HCPCS:17311)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks (HCPCS:17312)
• Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm (HCPCS:12032)
• Complicated or multiple drainage of skin abscess (HCPCS:10061)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• All potassium hydroxide (koh) preparations (HCPCS:Q0112)
• Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.0 sq cm or less (HCPCS:14040)
• Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less (HCPCS:15275)
• Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm (HCPCS:11603)
• Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm (HCPCS:17262)
• Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less (HCPCS:14060)
• Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm (HCPCS:11301)
• Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm (HCPCS:11602)
• Application of light by qualified health care professional to destroy precancer skin growth (HCPCS:96573)
• Biopsy of ear (HCPCS:69100)
• Removal of noncancer skin growth of body, arms, or legs, 2.1-3.0 cm (HCPCS:11403)
• Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm (HCPCS:11306)
• Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm (HCPCS:11311)
• Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm (HCPCS:17261)
• Tissue fungi or parasites (HCPCS:87220)
• Punch biopsy, first skin growth (HCPCS:11104)
• Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less (HCPCS:12031)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 6/16/2005 and was last updated on 3/7/2008.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.